Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes.

ABSTRACT:

Background

Acute coronary syndrome (ACS) is frequently accompanied by newly diagnosed atrial fibrillation (AF).

Aims

We aimed to compare the risk of major adverse cardiovascular events (MACE) in ACS patients presenting with known, newly diagnosed, or no AF.

Methods

In our multicentre, prospective registry study, we included patients with confirmed ACS. Patients are classified as having known, newly diagnosed or no AF. Newly diagnosed AF is subdivided according to the duration of the episode, time of onset, post-coronary artery bypass graft (CABG) or spontaneous occurrence, and treatment with oral anticoagulants (OAC). The primary endpoint is MACE at 1 year. Key secondary endpoints include ischaemic stroke and bleeding complications.

Results

Amongst 4,433 patien

SUBMITTER: Bor WLW 

PROVIDER: S-EPMC11317829 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature